Polyrizon (NASDAQ:PLRZ) Stock Price Down 1.8% – Time to Sell?

Polyrizon Ltd. (NASDAQ:PLRZ) shares fell 1.8% on Tuesday. The company traded as low as $8.54 and last traded at $8.8020. Approximately 5,287 shares changed hands during mid-day trading, The stock had previously closed at $8.96.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on PLRZ shares. Wall Street Zen downgraded shares of Polyrizon from a “hold” rating to a “sell” rating in a research report on Saturday, September 12th. Weiss Ratings lowered shares of Polyrizon from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, October 8th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Polyrizon Stock Performance

The business has a 50-day simple moving average of $10.58 and a two-hundred day simple moving average of $12.66.

Polyrizon (NASDAQ:PLRZ) last announced its quarterly earnings data on Monday, September 28th. The company reported ($0.40) earnings per share for the quarter.

About Polyrizon

Polyrizon Ltd. is a biotechnology company focused on developing nasal gels and other intranasal products designed to help protect against airborne allergens, pathogens and pollutants. Its proprietary hydrogel technology is intended to form a physical barrier within the nasal cavity, potentially limiting contact between inhaled particles and nasal tissue.

The company’s development programs are aimed at applications such as allergic rhinitis and the prevention or reduction of exposure to respiratory viruses and other airborne irritants.